Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,080 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00462943 | Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CML | completed | Phase 2 | 100 | Teva Branded Pharmaceutical Products R&D, Inc.INDUSTRY | 10 | Dec 28, 2021 | clinicaltrials |
| NCT05068076 | Role of Perfluorobutane in Lesion Detection, Targeting and Response Assessment for Ablation of HCC | completed | N/A | 21 | Institute of Liver and Biliary Sciences, IndiaOTHER | 1 | Dec 21, 2021 |
| clinicaltrials |
| NCT03511781 | Palliative Hypofractionated Radiotherapy in Advanced Incurable Breast Cancer(HYPORT) | completed | N/A | 30 | Tata Medical CenterOTHER | 1 | Dec 17, 2021 | clinicaltrials |
| NCT04249895 | Comprehensive Digital Archive of Cancer Imaging-Radiation Oncology( CHAVI-RO ) | completed | — | 500 | Tata Medical CenterOTHER | 1 | Dec 17, 2021 | clinicaltrials |
| NCT02726009 | A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer | completed | Phase 4 | 230 | Ferring PharmaceuticalsINDUSTRY | 1 | Dec 15, 2021 | clinicaltrials |
| NCT05144100 | Surgery Vs Chemoradiation for Oropharyngeal Cancer- A Phase II/III Integrated Design Randomized Control Trial(SCOPE) | not yet recruiting | Phase 2 / Phase 3 | 498 | Tata Memorial CentreOTHER | 1 | Dec 3, 2021 | clinicaltrials |
| NCT03338647 | SBRT or TACE for Advanced HCC | unknown | Phase 3 | 180 | University of AarhusOTHER | 1 | Dec 2, 2021 | clinicaltrials |
| NCT00375219 | Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation | completed | Phase 2 | 103 | Teva Branded Pharmaceutical Products R&D, Inc.INDUSTRY | 10 | Nov 15, 2021 | clinicaltrials |
| NCT05021861 | Evaluation of Periodontal Status and hsCRP Levels in Females With PCOS on CPA/EE Combination Drug Regimen | unknown | — | 150 | Postgraduate Institute of Dental Sciences RohtakOTHER | 1 | Nov 15, 2021 | clinicaltrials |
| NCT01587144 | Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM) | terminated | Phase 2 | 18 | Spectrum Pharmaceuticals, IncINDUSTRY | 2 | Oct 19, 2021 | clinicaltrials |
| NCT02551159 | Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer(KESTREL) | completed | Phase 3 | 823 | AstraZenecaINDUSTRY | 23 | Oct 13, 2021 | clinicaltrials |
| NCT02803385 | Comparison of Patient Controlled & Continuous Epidural Analgesia in Thoraco-abdominal Surgeries in Cancer Patients | completed | N/A | 70 | Tata Memorial CentreOTHER | 1 | Oct 6, 2021 | clinicaltrials |
| NCT04443049 | To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma. | unknown | N/A | 170 | Institute of Liver and Biliary Sciences, IndiaOTHER | 1 | Oct 5, 2021 | clinicaltrials |
| NCT05038501 | Prevalence of Comorbidities in Patients Undergoing Oncosurgeries at Tertiary Cancer Institute in North India.(oncosurgery) | completed | — | 150 | Rajiv Gandhi Cancer Institute & Research Center, IndiaOTHER | 1 | Oct 4, 2021 | clinicaltrials |
| NCT01077154 | Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE) | terminated | Phase 3 | 4,509 | AmgenINDUSTRY | 39 | Sep 28, 2021 | clinicaltrials |
| NCT01363479 | An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting | completed | Phase 3 | 743 | Helsinn Healthcare SAINDUSTRY | 12 | Sep 22, 2021 | clinicaltrials |
| NCT00553358 | Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study(Neo ALTTO) | completed | Phase 3 | 455 | Novartis PharmaceuticalsINDUSTRY | 24 | Sep 21, 2021 | clinicaltrials |
| NCT01646437 | The International Polycap Study 3 (TIPS-3)(TIPS-3) | completed | Phase 3 | 7,793 | Population Health Research InstituteOTHER | 9 | Sep 16, 2021 | clinicaltrials |
| NCT03604939 | Improving Access to Control of Diseases for Women(IMPACD) | completed | N/A | 1,200 | International Agency for Research on CancerOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT05022576 | Robotic-arm Assisted Ga-68 PSMA PET/CT Guided Transgluteal Prostate Biopsy | completed | N/A | 78 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Aug 26, 2021 | clinicaltrials |
| NCT04335227 | Yoga Therapy and Aerobic Exercise on Anti-Mullerian Hormone in Young Women With Polycystic Ovary Syndrome | unknown | N/A | 128 | Maharishi Markendeswar University (Deemed to be University)OTHER | 1 | Aug 24, 2021 | clinicaltrials |
| NCT02165215 | A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors(LAUREL) | completed | Phase 3 | 359 | Hoffmann-La RocheINDUSTRY | 15 | Aug 19, 2021 | clinicaltrials |
| NCT00694915 | Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder(STCC) | completed | Phase 2 | 122 | Cadila PharnmaceuticalsINDUSTRY | 1 | Aug 17, 2021 | clinicaltrials |
| NCT03722732 | Comparison of Blood Loss in Laparoscopic vs Open Pancreaticoduodenectomy in Patients With Periampullary Carcinoma | unknown | N/A | 36 | Govind Ballabh Pant HospitalOTHER_GOV | 1 | Aug 2, 2021 | clinicaltrials |
| NCT00713427 | Study of the WallFlex™ Biliary Partially-covered Stent for the Palliative Treatment of Malignant Bile Duct Obstruction | completed | N/A | 70 | Boston Scientific CorporationINDUSTRY | 6 | Jul 30, 2021 | clinicaltrials |
| NCT02038036 | Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy.(RESPONSE-2) | completed | Phase 3 | 149 | Novartis PharmaceuticalsINDUSTRY | 12 | Jul 20, 2021 | clinicaltrials |
| NCT00856375 | NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer | completed | Phase 2 | 83 | Nektar TherapeuticsINDUSTRY | 6 | Jul 12, 2021 | clinicaltrials |
| NCT02142907 | Evaluation of Two Boost Radiation Schedules in Post Lumpectomy Early Stage Carcinoma Breast | completed | — | 100 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Jun 23, 2021 | clinicaltrials |
| NCT04075058 | Hypofractionated Radiation Therapy in Patients With Breast Cancer(HRBC) | completed | Phase 3 | 1,070 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Jun 23, 2021 | clinicaltrials |
| NCT00545129 | A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone | completed | Phase 2 | 59 | PfizerINDUSTRY | 13 | Jun 18, 2021 | clinicaltrials |
| NCT03511378 | Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast Cancer | completed | Phase 4 | 138 | Lupin Ltd.INDUSTRY | 1 | Jun 15, 2021 | clinicaltrials |
| NCT03853551 | Osimertinib Study in Indian Patients | completed | Phase 4 | 60 | AstraZenecaINDUSTRY | 1 | Jun 3, 2021 | clinicaltrials |
| NCT01419665 | GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (ASSIST_FL)(ASSIST_FL) | completed | Phase 3 | 629 | SandozINDUSTRY | 26 | May 14, 2021 | clinicaltrials |
| NCT04660695 | Nasobiliary Drain Assisted EUS-guided Gastroenterostomies in Unresectable Malignant Gastric Outlet Obstruction(PENGUIN) | completed | — | 66 | Hospital del Rio HortegaOTHER | 2 | May 14, 2021 | clinicaltrials |
| NCT03296163 | A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)(STELLA) | completed | Phase 3 | 627 | mAbxience Research S.L.INDUSTRY | 18 | Apr 26, 2021 | clinicaltrials |
| NCT00704730 | Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer(EXAM) | completed | Phase 3 | 330 | ExelixisINDUSTRY | 24 | Apr 20, 2021 | clinicaltrials |
| NCT02778308 | Adjuvant Chemotherapy vs no Chemotherapy for Patients With GallBllader Carcinoma | completed | N/A | 100 | Govind Ballabh Pant Institute of Postgraduate Medical Education and ResearchOTHER_GOV | 1 | Apr 6, 2021 | clinicaltrials |
| NCT00830180 | Open Label Extension In Cancer Patients | completed | Phase 2 | 41 | PfizerINDUSTRY | 10 | Apr 5, 2021 | clinicaltrials |
| NCT03470948 | Surgical Apgar Score After Whipple Procedure in Pancreatic Cancer Patients | terminated | — | 263 | Tata Memorial HospitalOTHER_GOV | 1 | Apr 1, 2021 | clinicaltrials |
| NCT01479283 | Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY)(PARITY) | completed | Phase 3 | 602 | McMaster UniversityOTHER | 12 | Mar 11, 2021 | clinicaltrials |
| NCT00606502 | Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment | completed | Phase 2 | 201 | Spectrum Pharmaceuticals, IncINDUSTRY | 6 | Mar 5, 2021 | clinicaltrials |
| NCT01783444 | A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer.(BOLERO-6) | completed | Phase 2 | 309 | Novartis PharmaceuticalsINDUSTRY | 18 | Feb 26, 2021 | clinicaltrials |
| NCT03638622 | Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral Cancer Cancer.(UH3-India) | completed | Phase 1 / Phase 2 | 30 | Massachusetts General HospitalOTHER | 1 | Feb 21, 2021 | clinicaltrials |
| NCT04094974 | Heartrate Variability and Intraoperative Brain Conditions in Supratentorial Tumors | completed | — | 58 | DyAnsys, Inc.INDUSTRY | 1 | Jan 25, 2021 | clinicaltrials |
| NCT04712929 | Candida Associated Cytokines in Oral Leukoplakia | completed | — | 90 | All India Institute of Medical SciencesOTHER | 1 | Jan 20, 2021 | clinicaltrials |
| NCT00480025 | GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer | terminated | Phase 3 | 2,278 | GlaxoSmithKlineINDUSTRY | 34 | Dec 22, 2020 | clinicaltrials |
| NCT02788214 | Helicobacter Pylori Genome Project (HpGP) | terminated | — | 1,000 | National Cancer Institute (NCI)NIH | 53 | Dec 19, 2020 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials